0001209191-18-056046.txt : 20181024 0001209191-18-056046.hdr.sgml : 20181024 20181024161659 ACCESSION NUMBER: 0001209191-18-056046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181022 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASTRAZENECA PLC CENTRAL INDEX KEY: 0000901832 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 181136575 BUSINESS ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA BUSINESS PHONE: 011 44 20 7304 5000 MAIL ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA FORMER NAME: FORMER CONFORMED NAME: ZENECA GROUP PLC DATE OF NAME CHANGE: 19930422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zeneca, Inc. CENTRAL INDEX KEY: 0001657583 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 181136576 BUSINESS ADDRESS: STREET 1: 1800 CONCORD PIKE CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 800-236-9933 MAIL ADDRESS: STREET 1: 1800 CONCORD PIKE CITY: WILMINGTON STATE: DE ZIP: 19803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-22 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0000901832 ASTRAZENECA PLC 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA UNITED KINGDOM 0 0 1 0 0001657583 Zeneca, Inc. C/O ASTRAZENECA PLC 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA UNITED KINGDOM 0 0 1 0 Common Stock 2018-10-22 4 C 0 2404554 A 2404554 I By Zeneca, Inc. Common Stock 2018-10-22 4 P 0 600000 5.00 A 3004554 I By Zeneca, Inc. Warrants to Purchase Series C-1 Preferred Stock 0.12 2018-10-22 4 X 0 113891 0.00 D Series C-1 Preferred Stock 113891 0 I By Zeneca, Inc. Series C-1 Preferred Stock 2018-10-22 4 X 0 113891 0.12 A Common Stock 113891 1666951 I By Zeneca, Inc. Series C-1 Preferred Stock 2018-10-22 4 S 0 2734 5.00 D Common Stock 2734 1664217 I By Zeneca, Inc. Series C-1 Preferred Stock 2018-10-22 4 C 0 1664217 0.00 D Common Stock 1664217 0 I By Zeneca, Inc. Series D Preferred Stock 2018-10-22 4 C 0 740337 0.00 D Common Stock 740337 0 I By Zeneca, Inc. Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date. Zeneca Inc. is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the securities held by Zeneca Inc., but disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, if any. Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering. The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering. /s/ Adrian Kemp, on behalf of AstraZeneca PLC 2018-10-24 /s/ David E. White, on behalf of Zeneca Inc. 2018-10-24